The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studiesLANCET HEALTHY LONGEVITYIF14.62024-08-013PRE
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cellsNATURE COMMUNICATIONSIF15.72021-08-138OAAI
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEMBO MOLECULAR MEDICINEIF8.32019-05-2430OAAI
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinomaEUROPEAN JOURNAL OF CANCERIF7.12019-05-0131OAAI
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicityEMBO MOLECULAR MEDICINEIF8.32017-07-2058OAAI
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting CompoundsMOLECULAR CELLIF16.62016-02-01191OAAI
A unique inhibitor binding site in ERK1/2 is associated with slow binding kineticsNATURE CHEMICAL BIOLOGYIF13.72014-09-07196OAAI